ADenoVirus Initiative Study in Epidemiology in Italy
NCT03055065 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 241
Last updated 2017-02-16
Summary
The objectives of this study is to assess the characteristics and frequency of adenovirus conjunctivitis in a population of male and female patients from one year of age who present signs and symptoms of acute conjunctivitis.
Conditions
- Viral Conjunctivitis
Sponsors & Collaborators
-
NicOx
lead INDUSTRY
Principal Investigators
-
Paolo Fogagnolo, MD · Ospedale san Paolo Blocco
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-11-30
- Primary Completion
- 2015-10-31
- Completion
- 2015-10-31
Countries
- Italy
Study Locations
More Related Trials
-
AGN-229666 for the Treatment of Allergic Conjunctivitis
NCT01754766 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo
NCT02998554 ·Status: TERMINATED ·Phase: PHASE3
-
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
NCT00921895 ·Status: COMPLETED ·Phase: NA
-
OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis
NCT03856645 ·Status: UNKNOWN ·Phase: PHASE2
-
AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis
NCT02161146 ·Status: COMPLETED ·Phase: PHASE3
-
Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis
NCT00426023 ·Status: COMPLETED ·Phase: PHASE3
-
Lenticule Implantation and Autologous Serum New Approach in Treatment of Adenoviral Keratitis Disease
NCT05123014 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis
NCT05591755 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis
NCT01877694 ·Status: COMPLETED ·Phase: PHASE2
-
Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC)
NCT01977443 ·Status: COMPLETED ·Phase: PHASE2
-
AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis
NCT02082262 ·Status: COMPLETED ·Phase: PHASE3
-
Dermatologic Tacrolimus Ointment on Eyelids in the Treatment of Refractory Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis
NCT03557203 ·Status: UNKNOWN
-
FST-100 in the Treatment of Acute Adenoviral Conjunctivitis
NCT01470664 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
NCT01532336 ·Status: COMPLETED ·Phase: PHASE2
-
A Multi-Center Study Evaluating the Safety of AC-170 0.24%
NCT02132169 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
NCT02998541 ·Status: TERMINATED ·Phase: PHASE3
-
Assessment of the Effects and Tolerability of RD03/2016 for the Treatment of Bacterial Conjunctivitis in Adults
NCT06616922 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3)
NCT05360966 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of GV 550 in Acute Adenovirus Keratoconjunctivitis
NCT01156025 ·Status: COMPLETED ·Phase: PHASE2
-
COVID-19 Search in Conjunctival Cells
NCT04364594 ·Status: COMPLETED ·Phase: NA
-
A Study of ADX-102 in Subjects With Allergic Conjunctivitis
NCT03012165 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Feature and Treatment of Microsporidial Keratoconjunctivitis
NCT03555409 ·Status: UNKNOWN
-
Systemic Pharmacokinetics of BOL-303224-A
NCT00407589 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)
NCT00105469 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo
NCT03004924 ·Status: COMPLETED ·Phase: PHASE3